KERYX BIOPHARMACEUTICALS, INC. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementKeryx Biopharmaceuticals Inc • November 9th, 2016 • Pharmaceutical preparations • New York
Company FiledNovember 9th, 2016 Industry JurisdictionKeryx Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: